{"pmid":32347980,"title":"Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon.","text":["Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon.","A few studies have reported the long shedding of SARS-CoV-2 RNA. However, the duration of RNA shedding in Wuhan is rarely known and the meaning of the prolonged shedding is still under investigation. Almost 10% patients diagnosed of COVID-19 had a RNA shedding longer than 30 days even if the symptom elimination. The IgM was in a high level in the 9(th) week after symptom onset in these prolonged-RNA-shedding patients. Further study should be conducted to know the infectivity of the virus and the relationship between RNA shedding and antibody expression. This article is protected by copyright. All rights reserved.","J Med Virol","Li, Na","Wang, Xiao","Lv, Tangfeng","32347980"],"abstract":["A few studies have reported the long shedding of SARS-CoV-2 RNA. However, the duration of RNA shedding in Wuhan is rarely known and the meaning of the prolonged shedding is still under investigation. Almost 10% patients diagnosed of COVID-19 had a RNA shedding longer than 30 days even if the symptom elimination. The IgM was in a high level in the 9(th) week after symptom onset in these prolonged-RNA-shedding patients. Further study should be conducted to know the infectivity of the virus and the relationship between RNA shedding and antibody expression. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Li, Na","Wang, Xiao","Lv, Tangfeng"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347980","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/jmv.25952","keywords":["antibody","coronavirus","rna shedding"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1665441658346405888,"score":8.599203,"similar":[{"pmid":32271376,"title":"Factors associated with prolonged viral RNA shedding in patients with COVID-19.","text":["Factors associated with prolonged viral RNA shedding in patients with COVID-19.","BACKGROUND: An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public health emergency. Data are limited on the duration and host factors related to viral shedding. METHODS: In this retrospective study, risk factors associated with severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA shedding were evaluated in a cohort of 113 symptomatic patients from two hospitals outside Wuhan. RESULTS: The median duration of SARS-CoV-2 RNA detection was 17 days (Interquartile Range [IQR], 13-22 days) as measured from illness onset. When comparing patients with early (<15 days) and late viral RNA clearance (>/=15 days after illness onset), prolonged SARS-CoV-2 RNA shedding was associated with male sex (p=0.009), old age (p=0.033), concomitated with hypertension (p=0.009), delayed admission to hospital after illness onset (p=0.001), severe illness at admission (p=0.049), invasive mechanical ventilation (p=0.006), and corticosteroid treatment (p=0.025). Patients with longer SARS-CoV-2 RNA shedding duration had slower recovery of body temperature (p<0.001) and focal absorption on radiograph images (p<0.001) than patients with early SARS-CoV-2 RNA clearance. Male sex (odds ratio [OR], 3.24 [95% CI, 1.31-8.02]), delayed hospital admission (OR, 1.30 [95% CI, 1.10-1.54]), and invasive mechanical ventilation (OR, 9.88 [95% CI, 1.11-88.02]) were independent risk factors for prolonged SARS-CoV-2 RNA shedding. CONCLUSIONS: Male sex, delayed admission to hospital after illness onset, and invasive mechanical ventilation were associated with prolonged SARS-CoV-2 RNA shedding. Hospital admission and general treatments should be started as soon as possible in symptomatic COVID-19 patients, especially male patients.","Clin Infect Dis","Xu, Kaijin","Chen, Yanfei","Yuan, Jing","Yi, Ping","Ding, Cheng","Wu, Wenrui","Li, Yongtao","Ni, Qin","Zou, Rongrong","Li, Xiaohe","Xu, Min","Zhang, Ying","Zhao, Hong","Zhang, Xuan","Yu, Liang","Su, Junwei","Lang, Guanjing","Liu, Jun","Wu, Xiaoxin","Guo, Yongzheng","Tao, Jingjing","Shi, Ding","Yu, Ling","Cao, Qing","Ruan, Bing","Liu, Lei","Wang, Zhaoqin","Xu, Yan","Liu, Yingxia","Sheng, Jifang","Li, Lanjuan","32271376"],"abstract":["BACKGROUND: An outbreak of coronavirus disease 2019 (COVID-19) is becoming a public health emergency. Data are limited on the duration and host factors related to viral shedding. METHODS: In this retrospective study, risk factors associated with severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA shedding were evaluated in a cohort of 113 symptomatic patients from two hospitals outside Wuhan. RESULTS: The median duration of SARS-CoV-2 RNA detection was 17 days (Interquartile Range [IQR], 13-22 days) as measured from illness onset. When comparing patients with early (<15 days) and late viral RNA clearance (>/=15 days after illness onset), prolonged SARS-CoV-2 RNA shedding was associated with male sex (p=0.009), old age (p=0.033), concomitated with hypertension (p=0.009), delayed admission to hospital after illness onset (p=0.001), severe illness at admission (p=0.049), invasive mechanical ventilation (p=0.006), and corticosteroid treatment (p=0.025). Patients with longer SARS-CoV-2 RNA shedding duration had slower recovery of body temperature (p<0.001) and focal absorption on radiograph images (p<0.001) than patients with early SARS-CoV-2 RNA clearance. Male sex (odds ratio [OR], 3.24 [95% CI, 1.31-8.02]), delayed hospital admission (OR, 1.30 [95% CI, 1.10-1.54]), and invasive mechanical ventilation (OR, 9.88 [95% CI, 1.11-88.02]) were independent risk factors for prolonged SARS-CoV-2 RNA shedding. CONCLUSIONS: Male sex, delayed admission to hospital after illness onset, and invasive mechanical ventilation were associated with prolonged SARS-CoV-2 RNA shedding. Hospital admission and general treatments should be started as soon as possible in symptomatic COVID-19 patients, especially male patients."],"journal":"Clin Infect Dis","authors":["Xu, Kaijin","Chen, Yanfei","Yuan, Jing","Yi, Ping","Ding, Cheng","Wu, Wenrui","Li, Yongtao","Ni, Qin","Zou, Rongrong","Li, Xiaohe","Xu, Min","Zhang, Ying","Zhao, Hong","Zhang, Xuan","Yu, Liang","Su, Junwei","Lang, Guanjing","Liu, Jun","Wu, Xiaoxin","Guo, Yongzheng","Tao, Jingjing","Shi, Ding","Yu, Ling","Cao, Qing","Ruan, Bing","Liu, Lei","Wang, Zhaoqin","Xu, Yan","Liu, Yingxia","Sheng, Jifang","Li, Lanjuan"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271376","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cid/ciaa351","keywords":["covid-19","coronavirus","sars-cov-2","risk factors","viral shedding"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664637315636527105,"score":354.08313},{"pmid":32243607,"title":"The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.","text":["The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.","BACKGROUND: In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients. METHODS: Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness. RESULTS: A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients. CONCLUSIONS: Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved.","J Med Virol","Chen, Yifei","Chen, Liangjun","Deng, Qiaoling","Zhang, Guqin","Wu, Kaisong","Ni, Lan","Yang, Yibin","Liu, Bing","Wang, Wei","Wei, Chaojie","Yang, Jiong","Ye, Guangming","Cheng, Zhenshun","32243607"],"abstract":["BACKGROUND: In December 2019, Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China, and has spread globally. However, the transmission route of SARS-CoV-2 has not been fully understood. In this study, we aimed to investigate the SARS-CoV-2 shedding in excreta of COVID-19 patients. METHODS: Electronical medical records, including demographics, clinical characteristics, laboratory and radiological findings, of enrolled patients were extracted and analyzed. Pharyngeal swab, stool and urine specimens were collected and tested for SARS-CoV-2 RNA by RT-PCR. Viral shedding at multiple time points in specimens was recorded, and analyzed its correlation with clinical manifestations and the severity of illness. RESULTS: A total of 42 laboratory-confirmed patients were enrolled, 8 (19.05%) of whom had gastrointestinal symptoms. 28 (66.67%) patients tested positive for SARS-CoV-2 RNA in stool specimens, which was not associated with the presence of gastrointestinal symptoms and the severity of illness. Among them, 18 (64.29%) patients remained positive for viral RNA in feces after pharyngeal swabs turned negative. The duration of viral shedding from feces after negative conversion in pharyngeal swabs was 7 (6-10) days, regardless of COVID-19 severity. The demographics, clinical characteristics, laboratory and radiologic findings did no differ between patients tested positive and negative for SARS-CoV-2 RNA in feces. Viral RNA was not detectable in urine specimens from 10 patients. CONCLUSIONS: Our results demonstrated the presence of SARS-CoV-2 RNA in feces of COVID-19 patients, and suggested the possibility of SARS-CoV-2 transmission via the fecal-oral route. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Chen, Yifei","Chen, Liangjun","Deng, Qiaoling","Zhang, Guqin","Wu, Kaisong","Ni, Lan","Yang, Yibin","Liu, Bing","Wang, Wei","Wei, Chaojie","Yang, Jiong","Ye, Guangming","Cheng, Zhenshun"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243607","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25825","keywords":["coronavirus disease 2019","fecal-oral transmission","severe acute respiratory syndrome coronavirus 2","viral rna","viral shedding"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China","Feces"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638249317957632,"score":269.17856},{"pmid":32226287,"pmcid":"PMC7098032","title":"Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.","text":["Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau.","As a city famous for tourism, the public healthcare system of Macau SAR has been under great pressure during the outbreak of the Coronavirus Disease 2019 (COVID-19). In this study, we report clinical and microbiological features of ten COVID-19 patients enrolled in the Centro Hospitalar Conde de Sao Januario (CHCSJ) between January 21 to February 16, 2020. Clinical samples from all patients including nasopharyngeal swab (NPS)/sputum, urine, and feces were collected for serial virus RNA testing by standard qRT-PCR assay. In total, seven were imported cases and three were local cases. The median duration from Macau arrival to admission in imported cases was 3 days. Four patients required oxygen therapy but none of them needed machinal ventilation. No fatal cases were noted. The most common symptoms were fever (80%) and diarrhea (80%). In the \"Severe\" group, there was significantly more elderly patients (p=0.045), higher lactate dehydrogenase levels (p=0.002), and elevated C-Reactive protein levels compared to the \"Mild to Moderate\" group (p<0.001). There were positive SARS-CoV-2 RNA signals in all patients' NPS and stool specimens but negative in all urine specimens. Based on our data on SARS-CoV-2 RNA shedding in stool and the possibility of a lag in viral detection in NPS specimens, the assessment of both fecal and respiratory specimen is recommended to enhance diagnostic sensitivity, and also to aid discharge decision before the role of viral RNA shedding in stool is clarified.","Int J Biol Sci","Lo, Iek Long","Lio, Chon Fu","Cheong, Hou Hon","Lei, Chin Ion","Cheong, Tak Hong","Zhong, Xu","Tian, Yakun","Sin, Nin Ngan","32226287"],"abstract":["As a city famous for tourism, the public healthcare system of Macau SAR has been under great pressure during the outbreak of the Coronavirus Disease 2019 (COVID-19). In this study, we report clinical and microbiological features of ten COVID-19 patients enrolled in the Centro Hospitalar Conde de Sao Januario (CHCSJ) between January 21 to February 16, 2020. Clinical samples from all patients including nasopharyngeal swab (NPS)/sputum, urine, and feces were collected for serial virus RNA testing by standard qRT-PCR assay. In total, seven were imported cases and three were local cases. The median duration from Macau arrival to admission in imported cases was 3 days. Four patients required oxygen therapy but none of them needed machinal ventilation. No fatal cases were noted. The most common symptoms were fever (80%) and diarrhea (80%). In the \"Severe\" group, there was significantly more elderly patients (p=0.045), higher lactate dehydrogenase levels (p=0.002), and elevated C-Reactive protein levels compared to the \"Mild to Moderate\" group (p<0.001). There were positive SARS-CoV-2 RNA signals in all patients' NPS and stool specimens but negative in all urine specimens. Based on our data on SARS-CoV-2 RNA shedding in stool and the possibility of a lag in viral detection in NPS specimens, the assessment of both fecal and respiratory specimen is recommended to enhance diagnostic sensitivity, and also to aid discharge decision before the role of viral RNA shedding in stool is clarified."],"journal":"Int J Biol Sci","authors":["Lo, Iek Long","Lio, Chon Fu","Cheong, Hou Hon","Lei, Chin Ion","Cheong, Tak Hong","Zhong, Xu","Tian, Yakun","Sin, Nin Ngan"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226287","week":"202014|Mar 30 - Apr 05","doi":"10.7150/ijbs.45357","keywords":["covid-19","macau","sars-cov-2","nasopharyngeal swab","novel coronavirus","qrt-pcr","sputum","stool","urine"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640912733503488,"score":237.56487},{"pmid":32335406,"title":"Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.","text":["Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19.","Factors associated with negative conversion of SARS-CoV-2 RNA in hospitalized patients have not yet been systematically determined. We conducted a retrospective cohort study of COVID-19 patients in Qingdao, China. Both univariate and multivariate analysis were performed to identify independent factors for time to viral RNA negative conversion. Data on patients with re-detectable viral RNA after showing negative on RT-PCR test (intermittent negative status) were also analyzed. A total of 59 patients confirmed with COVID-19 were included in this study, with a median duration of 1 (interquartile range, IQR: 0-2) day from symptom onset to hospital admission. Median communicable period (from first day of positive nucleic acid test to first day of consecutive negative results) was 14 (IQR: 10-18) days, and 7 (IQR: 6-10) days for 10 patients with intermittent negative results. Age older than 45 years (hazard ratio, HR: 0.378; 95% confidence interval, CI: 0.205-0.698) and chest tightness (HR: 0.290; 95%CI: 0.091-0.919) were factors indecently affecting negative conversion of SARS-CoV-2 RNA. Headache (odds ratio: 7.553; 95%CI: 1.011-28.253) was significantly associated with intermittent negative status, with a predicted probability of 60%. Older age and chest tightness were independently associated with delayed clearance of SARS-CoV-2 RNA in hospitalized patients. These predictors would provide a new perspective on early identification of patients with prolonged viral shedding and facilitate optimal isolation protocols and treatment strategies.","Sci Total Environ","Hu, Xiaowen","Xing, Yuhan","Jia, Jing","Ni, Wei","Liang, Jiwei","Zhao, Dan","Song, Xin","Gao, Ruqin","Jiang, Fachun","32335406"],"abstract":["Factors associated with negative conversion of SARS-CoV-2 RNA in hospitalized patients have not yet been systematically determined. We conducted a retrospective cohort study of COVID-19 patients in Qingdao, China. Both univariate and multivariate analysis were performed to identify independent factors for time to viral RNA negative conversion. Data on patients with re-detectable viral RNA after showing negative on RT-PCR test (intermittent negative status) were also analyzed. A total of 59 patients confirmed with COVID-19 were included in this study, with a median duration of 1 (interquartile range, IQR: 0-2) day from symptom onset to hospital admission. Median communicable period (from first day of positive nucleic acid test to first day of consecutive negative results) was 14 (IQR: 10-18) days, and 7 (IQR: 6-10) days for 10 patients with intermittent negative results. Age older than 45 years (hazard ratio, HR: 0.378; 95% confidence interval, CI: 0.205-0.698) and chest tightness (HR: 0.290; 95%CI: 0.091-0.919) were factors indecently affecting negative conversion of SARS-CoV-2 RNA. Headache (odds ratio: 7.553; 95%CI: 1.011-28.253) was significantly associated with intermittent negative status, with a predicted probability of 60%. Older age and chest tightness were independently associated with delayed clearance of SARS-CoV-2 RNA in hospitalized patients. These predictors would provide a new perspective on early identification of patients with prolonged viral shedding and facilitate optimal isolation protocols and treatment strategies."],"journal":"Sci Total Environ","authors":["Hu, Xiaowen","Xing, Yuhan","Jia, Jing","Ni, Wei","Liang, Jiwei","Zhao, Dan","Song, Xin","Gao, Ruqin","Jiang, Fachun"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335406","week":"202018|Apr 27 - May 03","doi":"10.1016/j.scitotenv.2020.138812","keywords":["coronavirus disease 2019 (covid-19)","hazard ratio","negative conversion","severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["Qingdao","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1665172302003699713,"score":225.13116},{"pmid":32342849,"title":"Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19).","text":["Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19).","Novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has become a public health emergency of international concern. This was first noted in Wuhan, Hubei Province, China, and since then has become widespread globally. We report a 71-year-old woman with documented viral shedding (based on reverse transcription-polymerase chain reaction (RT-PCR) testing) of SARS-CoV-2 for 60 days from the onset of symptoms (55 days from her first positive test and 36 days after complete resolution of symptoms). This is to our knowledge the longest duration of viral shedding reported to date. This case demonstrates that viral shedding after COVID-19 diagnosis can be prolonged.","Am J Trop Med Hyg","Li, Junyao","Zhang, Lin","Liu, Baihui","Song, Debiao","32342849"],"abstract":["Novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has become a public health emergency of international concern. This was first noted in Wuhan, Hubei Province, China, and since then has become widespread globally. We report a 71-year-old woman with documented viral shedding (based on reverse transcription-polymerase chain reaction (RT-PCR) testing) of SARS-CoV-2 for 60 days from the onset of symptoms (55 days from her first positive test and 36 days after complete resolution of symptoms). This is to our knowledge the longest duration of viral shedding reported to date. This case demonstrates that viral shedding after COVID-19 diagnosis can be prolonged."],"journal":"Am J Trop Med Hyg","authors":["Li, Junyao","Zhang, Lin","Liu, Baihui","Song, Debiao"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342849","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.4269/ajtmh.20-0275","locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1665351883827445760,"score":224.60884}]}